UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AN ANXIOLYTIC-LIKE ACTION OF CLONIDINE AND MORPHINE WHICH IS NALOXONE-REVERSIBLE

Journal of pharmacy and pharmacology, 2011-04, Vol.32 (S1), p.43P-43P

2011

Volltextzugriff (PDF)

Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder

Neuro-endocrinology letters, 2002-02, Vol.23 (1), p.45-48

2002

Volltextzugriff (PDF)

Characterization of the discriminable stimulus produced by 2‐BFI: effects of imidazoline I2‐site ligands, MAOIs, β‐carbolines, agmatine and ibogaine

British journal of pharmacology, 2002-03, Vol.135 (5), p.1227-1234

2002

Volltextzugriff (PDF)

Potential serotonergic and noradrenergic involvement in the discriminative stimulus effects of the selective imidazoline I2-site ligand 2-BFI

Pharmacology, biochemistry and behavior, 2003-05, Vol.75 (2), p.427-433

2003

Volltextzugriff (PDF)

Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain

European journal of pharmacology, 2005-06, Vol.516 (2), p.139-144

2005

Volltextzugriff (PDF)

Evaluation of marble-burying behavior as a model of anxiety

Pharmacology, biochemistry and behavior, 1991, Vol.38 (1), p.63-67

1991

Volltextzugriff (PDF)

Chronic administration of 2-(2-benzofuranyl)-2-imidazoline (2-BFI) induces region-specific increases in [3H]2-BFI binding to rat central imidazoline I2 sites

Neuroscience letters, 2004-06, Vol.363 (1), p.11-13

2004

Volltextzugriff (PDF)

Region-dependent effects of acute and chronic tranylcypromine in vivo on [3H]2-BFI binding to brain imidazoline I2 sites

European journal of pharmacology, 2001-10, Vol.428 (2), p.221-225

2001

Volltextzugriff (PDF)

Increased 5-HT2A receptor expression and function following central glucocorticoid receptor knockdown in vivo

European journal of pharmacology, 2004-10, Vol.502 (3), p.213-220

2004

Volltextzugriff (PDF)

Characterization of the discriminable stimulus produced by 2‐BFI: effects of imidazoline I 2 ‐site ligands, MAOIs, β‐carbolines, agmatine and ibogaine

British journal of pharmacology, 2009-02, Vol.135 (5), p.1227-1234

2009

Volltextzugriff (PDF)

The thyrotrophin-releasing hormone analogue MK771 induces tic-like behaviours: the effects of dopamine D1 and D2 receptor antagonists

European journal of pharmacology, 1999-03, Vol.369 (1), p.1-9

1999

Volltextzugriff (PDF)

The effects of α2‐adrenoceptor antagonists on the inhibition of 1‐(2,5‐dimethoxy‐4‐iodophenyl)‐2‐aminopropane (DOI)‐induced head shakes by 5‐HT1A receptor agonists in the mouse

British journal of pharmacology, 1993-08, Vol.109 (4), p.1046-1052

1993

Volltextzugriff (PDF)

5-Hydroxytryptamine pathways in anxiety and its treatment

Pharmacology & therapeutics (Oxford), 1995-01, Vol.66 (1), p.103-148

Handley, Sheila L.

1995

Volltextzugriff (PDF)

Chronic administration of the cholesterol reducing drug gemfibrozil fails to alter 5-HT1A and 5-HT2A mediated receptor behaviours in rats

Journal of psychopharmacology (Oxford), 2000-05, Vol.14 (3), p.280-283

2000

Volltextzugriff (PDF)

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

Journal of psychopharmacology (Oxford), 2001-09, Vol.15 (3), p.181-186

2001

Volltextzugriff (PDF)

Quinolinic acid inhibits DOI-induced head shakes in mice

Journal of psychopharmacology (Oxford), 1999-05, Vol.13 (3), p.284-285

1999

Volltextzugriff (PDF)

Autoradiographic localisation of [ 3H]2-BFI imidazoline I 2 binding sites in mouse brain

European journal of pharmacology, 2005-06, Vol.516 (2), p.139-144

2005

Volltextzugriff (PDF)

Kynurenine potentiates the DOI head shake in mice

Journal of psychopharmacology (Oxford), 1995-01, Vol.9 (1), p.69-70

1995

Volltextzugriff (PDF)

Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I2-site ligands, MAOIs, [beta]-carbolines, agmatine and ibogaine

British journal of pharmacology, 2002-03, Vol.135 (5), p.1227

2002

Volltextzugriff (PDF)

Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine

British journal of pharmacology, 2002-03, Vol.135 (5), p.1227-1234

2002

Volltextzugriff (PDF)

Kynurenine potentiates the DOI head shake in mice

Journal of psychopharmacology (Oxford), 1995-01, Vol.9 (4), p.402-402

1995

Volltextzugriff (PDF)

5-HT-the disengaging transmitter?

Journal of psychopharmacology (Oxford), 1991, Vol.5 (4), p.322-326

1991

Volltextzugriff (PDF)

Potential serotonergic and noradrenergic involvement in the discriminative stimulus effects of the selective imidazoline I 2-site ligand 2-BFI

Pharmacology, biochemistry and behavior, 2003-05, Vol.75 (2), p.427-433

2003

Volltextzugriff (PDF)

Serotonin, eating disorders, and HIV infection

British journal of psychiatry, 1992-06, Vol.160 (6), p.866-867

1992

Volltextzugriff (PDF)

Complex of rapid movements and vocalization induced by RX336-M in mice: possible relevance to Tourette's syndrome

Journal of psychopharmacology (Oxford), 1994-01, Vol.8 (1), p.27-31

1994

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(73)
Reviews
(1)

Sprache

Englisch
(74)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Pharmacology & Pharmacy
(32)
Animals
(29)
Male
(27)
Biological And Medical Sciences
(26)
Neurosciences
(25)
Neurosciences & Neurology
(25)
Medical Sciences
(22)
Humans
(20)
Mice
(18)
Psychiatry
(18)
Female
(16)
Pharmacology. Drug Treatments
(13)
Neuropharmacology
(11)
Rats
(11)
Clinical Neurology
(9)
Psychology. Psychoanalysis. Psychiatry
(9)
Dose-Response Relationship, Drug
(8)
Drug Synergism
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

AN ANXIOLYTIC-LIKE ACTION OF CLONIDINE AND MORPHINE WHICH IS NALOXONE-REVERSIBLE

Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder

Characterization of the discriminable stimulus produced by 2‐BFI: effects of imidazoline I2‐site ligands, MAOIs, β‐carbolines, agmatine and ibogaine

Potential serotonergic and noradrenergic involvement in the discriminative stimulus effects of the selective imidazoline I2-site ligand 2-BFI

Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain

Evaluation of marble-burying behavior as a model of anxiety

Chronic administration of 2-(2-benzofuranyl)-2-imidazoline (2-BFI) induces region-specific increases in [3H]2-BFI binding to rat central imidazoline I2 sites

Region-dependent effects of acute and chronic tranylcypromine in vivo on [3H]2-BFI binding to brain imidazoline I2 sites

Increased 5-HT2A receptor expression and function following central glucocorticoid receptor knockdown in vivo

Characterization of the discriminable stimulus produced by 2‐BFI: effects of imidazoline I 2 ‐site ligands, MAOIs, β‐carbolines, agmatine and ibogaine

The thyrotrophin-releasing hormone analogue MK771 induces tic-like behaviours: the effects of dopamine D1 and D2 receptor antagonists

The effects of α2‐adrenoceptor antagonists on the inhibition of 1‐(2,5‐dimethoxy‐4‐iodophenyl)‐2‐aminopropane (DOI)‐induced head shakes by 5‐HT1A receptor agonists in the mouse

5-Hydroxytryptamine pathways in anxiety and its treatment

Chronic administration of the cholesterol reducing drug gemfibrozil fails to alter 5-HT1A and 5-HT2A mediated receptor behaviours in rats

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

Quinolinic acid inhibits DOI-induced head shakes in mice

Autoradiographic localisation of [ 3H]2-BFI imidazoline I 2 binding sites in mouse brain

Kynurenine potentiates the DOI head shake in mice

Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I2-site ligands, MAOIs, [beta]-carbolines, agmatine and ibogaine

Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine

Kynurenine potentiates the DOI head shake in mice

5-HT-the disengaging transmitter?

Potential serotonergic and noradrenergic involvement in the discriminative stimulus effects of the selective imidazoline I 2-site ligand 2-BFI

Serotonin, eating disorders, and HIV infection

Complex of rapid movements and vocalization induced by RX336-M in mice: possible relevance to Tourette's syndrome

Suchergebnisse filtern